GSK’s candidate Shingles Vaccine Containing Agenus’ QS-21 Stimulon® Demonstrates 90% Efficacy against Shingles and 89% Efficacy against Post-Herpetic Neuralgia in Adults aged 70 Yea
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| AGENUS (NASDAQ: AGEN) | Delayed: 6.33 -0.18 (2.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.51 | 52 Week High | $7.49 | |||
| Open | $6.36 | 52 Week Low | $2.61 | |||
| Day High | $6.50 | P/E | N/A | |||
| Day Low | $6.16 | EPS | $-1.10 | |||
| Volume | 510,113 | |||||
| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 50.75 -0.46 (0.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $51.21 | 52 Week High | $45.58 | |||
| Open | $50.83 | 52 Week Low | $37.82 | |||
| Day High | $50.92 | P/E | N/A | |||
| Day Low | $50.29 | EPS | $0.00 | |||
| Volume | 3,178,908 | |||||
